Cargando…
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration
The pharmacokinetics of enflicoxib were evaluated in both a bioavailability study and a multi‐dose safety study in Beagle dogs. When administered at 8 mg/kg, the oral bioavailability (F) of enflicoxib was 44.1% in fasted dogs, but F increased to 63.4% under post prandial conditions. Enflicoxib is ra...
Autores principales: | Homedes, Josep, Salichs, Marta, Solà, Josep, Menargues, Angel, Cendrós, Josep‐Maria, Encina, Gregorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291756/ https://www.ncbi.nlm.nih.gov/pubmed/34160092 http://dx.doi.org/10.1111/jvp.12995 |
Ejemplares similares
-
Comparative In vitro Metabolism of Enflicoxib in Dogs, Rats, and Humans: Main Metabolites and Proposed Metabolic Pathways
por: Solà, Josep, et al.
Publicado: (2021) -
Pharmacology of enflicoxib, a new coxib drug: Efficacy and dose determination by clinical and pharmacokinetic‐guided approach for the treatment of osteoarthritis in dogs based on an acute arthritis induction model
por: Cendrós, Josep‐Maria, et al.
Publicado: (2021) -
Selective inhibition of cyclooxygenase‐2 by enflicoxib, its enantiomers and its main metabolites in vitro in canine blood
por: Solà, Josep, et al.
Publicado: (2022) -
Long-term safety evaluation of Daxocox(®) tablets (enflicoxib) in dogs after weekly oral administrations for seven months
por: Homedes, Josep, et al.
Publicado: (2021) -
Evaluation of the Genotoxic Potential of the Selective COX-2
Inhibitor Enflicoxib in a Battery of
in vitro
and
in vivo
Genotoxicity Assays
por: Guzmán, Antonio, et al.
Publicado: (2022)